phase 0_trial_completion
saveUniversity of Pennsylvania — ubidecarenone (Phase 0 Trial Completion)
community read0 votes
Therapy area: Central Nervous System, Gastrointestinal. Indication: Crohn's Disease (Regional Enteritis), Fatigue
Data sources
globaldata
Found something off?
same company · ±60 days · 6
- grantUNIVERSITY OF PENNSYLVANIA — Metabolic Imaging Using Hyperpolarized Agents at Tracer ConcentrationsApr 16, 2026
- grantUNIVERSITY OF PENNSYLVANIA — The Maternal Immune Axis Programs Fetal CorticogenesisApr 15, 2026
- grantUNIVERSITY OF PENNSYLVANIA — 3D MRI Method for CMRO2 Mapping of the Brain in DementiaApr 15, 2026
- grantUNIVERSITY OF PENNSYLVANIA — SPARC: A sustainable data repository for datasets and tools bridging the body...Apr 15, 2026
- grantUNIVERSITY OF PENNSYLVANIA — Impact of Mechanical Circulatory Support and Microbiome Change on Outcomes in...Apr 14, 2026
- grantUNIVERSITY OF PENNSYLVANIA — Defining the determinants of long term CAR-T persistenceApr 10, 2026
related news · 8
- statOpinion: Access to air conditioning is critical preventive care. But federal policy treats it as optional
- statOpinion: AI doctors should be licensed. Here’s a framework to do that
- statOpinion: We need more men in nursing
- statOpinion: STAT+: Ambiguous loss: a peculiar kind of grief in dementia care
- statIn first meeting, federal autism committee focuses on ‘profound autism’
- statSTAT+: FDA launches effort to speed up clinical trials, using AI
- statOpinion: FDA commissioner: ‘Smarter,’ real-time clinical trials could transform drug development
- statHeart’s beat may help it beat cancer, mouse research suggests
comments(0)
5-min edit window · permanent after that